The COVID-19 vaccines currently being administered, or considered, in the MENA region

Over the past month, a number of COVID-19 vaccines have been approved for general or emergency use in the Middle East and North Africa (MENA). In our previous article, we looked at the main 4 types of vaccine – and the pros and cons of each one.

Now, using data collated by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, along with various regional government media statements, we bring you a roundup of the actual COVID-19 vaccines currently circulating in the MENA. The most common ones at the moment, in no particular order, are by Sinopharm, Sinovac, Pfizer-BioNTech, Moderna, Oxford-AstraZeneca, and Sputnik V (Gamaleya Research Institute). Here’s what’s known about them.

Editor’s note: Information is accurate at time of publishing; however, given the ongoing updates in research – plus possible changes in governmental decisions – the availability and reliability of these vaccines is subject to change at any time.

 

1) WHOLE VIRUS VACCINE

Sinopharm (Beijing Institute of Biological Products)

Total number in registered trials: 56,128

Efficacy data: 79% in a press release; no supporting details reportedly provided

Storage requirements: Refrigeration (2°C to 8°C)

Manufacture projections: No official information; up to 1 billion doses in

Your Year in Fitness 2020

Bodybuilding.com is the largest and strongest fitness community in the world. It’s where people like you come to find trusted supplements at great prices, workouts, recipes, motivation, comprehensive plans (BodyFit),...